Literature DB >> 3262998

MR imaging of the cavernous sinus: value of spin echo and gradient recalled echo images.

D L Daniels1, L F Czervionke, J F Bonneville, F Cattin, L P Mark, P Pech, L E Hendrix, D F Smith, V M Haughton, A L Williams.   

Abstract

A detailed evaluation of the MR appearance of the pituitary gland-cavernous sinus junction has not been described. In a series of coronal T1-weighted spin echo images without and with IV gadolinium, we noted the variable size and signal intensity of cavernous venous spaces adjacent to the pituitary gland and the inconsistent visualization of the dural membrane just lateral to the gland. Correlation of coronal T1-weighted spin echo and gradient recalled echo images (the latter with high-signal-intensity vascular structures) proved to be an effective means of identifying cavernous venous spaces, connective tissue and cranial nerves, and the lateral margins of the pituitary gland, and of differentiating tumor tissue from cavernous venous spaces. Further work is needed to develop criteria to distinguish cavernous sinus compression from actual tumor invasion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262998     DOI: 10.2214/ajr.151.5.1009

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  CT and high-field MRI in septic thrombosis of the cavernous sinuses.

Authors:  E Ellie; B Houang; C Louail; V Legrain-Lifermann; F Laurent; J Drouillard; J Julien
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  Normal cranial nerves in the cavernous sinuses: contrast-enhanced three-dimensional constructive interference in the steady state MR imaging.

Authors:  Akiko Yagi; Noriko Sato; Ayako Taketomi; Takahito Nakajima; Hideo Morita; Yoshinori Koyama; Jun Aoki; Keigo Endo
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

3.  Paraseller meningiomas: incidence of involvement of extracavernous structures as determined by magnetic resonance and computed tomography.

Authors:  G Lanzino; W L Hirsch; S Pomonis; L N Sekhar
Journal:  Skull Base Surg       Date:  1993

4.  Diagnosis of carotid-cavernous fistulas with magnetic resonance angiography--demonstrating the draining veins utilizing 3-D time-of-flight and 3-D phase-contrast techniques.

Authors:  F Ikawa; T Uozumi; K Kiya; K Kurisu; K Arita; M Sumida
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

5.  Added value of contrast-enhanced CISS imaging in relation to conventional MR images for the evaluation of intracavernous cranial nerve lesions.

Authors:  Akiko Yagi; Noriko Sato; Ayako Takahashi; Hideo Morita; Makoto Amanuma; Keigo Endo; K Takeuchi
Journal:  Neuroradiology       Date:  2010-04-10       Impact factor: 2.804

6.  Gradient recalled echo MR imaging of superior sagittal sinus occlusion.

Authors:  D L Daniels; L F Czervionke; L E Hendrix; L P Mark; D F Smith; G A Meyer; D J Maiman; V M Haughton; A L Williams
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

7.  Cavernous sinus thrombosis of nasal origin in children.

Authors:  Saurabh Varshney; Manu Malhotra; Pratima Gupta; Priyanka Gairola; Navjot Kaur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2014-11-27

Review 8.  Giant Chondroma of the Saddle Area: Case Report and Literature Review.

Authors:  Lubin Qiu; Yongjun Zhu; Haijun Wang; Yatang Wang; Qiang Wu; Jianming Yang
Journal:  Neuroophthalmology       Date:  2013-11-19

9.  Retrograde flow in the left inferior petrosal sinus and blood steal of the cavernous sinus associated with central vein stenosis: MR angiographic findings.

Authors:  Yahya Paksoy; Bülent Oğuz Genç; Emine Genç
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

10.  Follow-up MRI in dural arteriovenous malformations involving the cavernous sinus: emphasis on detection of venous thrombosis.

Authors:  N Hirabuki; N Fujita; T Hashimoto; K Fujii; T Miura; M Mitomo; R Kawai; T Kozuka
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.